Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Oxymetazoline (0.01% w/v) Nasal Spray
Therapeutic Category
Respiratory, Cold and Cough, ENT
Dosage Form
Nasal Spray
Packaging Type
Dropper
Packaging
10ml
Price
₹0/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oxyniff Mini Nasal Spray contains Oxymetazoline 0.01% w/v, a fast-acting nasal decongestant used for nasal congestion, sinus blockage, and allergy-related nasal obstruction.
Oxymetazoline works by constricting blood vessels in the nasal passages, providing quick relief from stuffiness and improved breathing. Its formulation ensures safe and effective repeated use within recommended dosage.
Clinically, Oxyniff Mini Nasal Spray is widely used in ENT clinics, pharmacies, and home care, offering rapid symptomatic relief and high patient satisfaction.
From a business perspective, Oxyniff Mini Nasal Spray strengthens the nasal care segment, delivering consistent prescription demand, repeat sales, and profitable PCD pharma franchise opportunities at a best price for franchise partners.
Common side effects may include mild stinging, burning, or dryness in the nasal passages. Rarely, prolonged use may lead to rebound congestion, headache, dizziness, or elevated blood pressure.
Oxyniff Mini Nasal Spray is indicated for the temporary relief of nasal congestion associated with allergic rhinitis, common cold, sinusitis, or upper respiratory tract infections. It helps open nasal passages and improve breathing.
Use Oxyniff Mini Nasal Spray strictly as directed by a healthcare professional. Do not exceed the recommended dosage or duration of use (usually not more than 3–5 days) to avoid rebound congestion. Discontinue and consult a doctor if severe irritation, persistent congestion, or unusual symptoms occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Propionate (0.005% w/v)
Composition : Mometasone (50mcg)
Composition : Xylometazoline (0.1% w/v)
Composition : Xylometazoline (0.05% w/v)
Composition : Sodium Chloride I.P. 0.65% w/v + Benzalkonium Chloride Solution I.P. 0.02% w/v Nasal Drop
Composition : Mometasone Furoate (50mcg) + Azelastine Hydrochloride (140mcg) Nasal Spray
Composition : Calcitonin 200IU Nasal spray
Composition : Oxymetazoline (0.025% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Oxymetazoline 0.01% w/v Nasal Spray has strong demand in the ENT, respiratory care, allergy care, and pediatric healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on nasal care and respiratory health portfolios.
Medical distributors and agencies can benefit from consistent demand for nasal congestion relief under medical supervision. Oxymetazoline 0.01% w/v is a topical nasal decongestant that helps constrict swollen blood vessels in the nasal passages Commonly prescribed for nasal congestion associated with common cold, allergic rhinitis, sinusitis, and upper respiratory tract conditions Helps provide rapid relief from blocked nose and improves breathing comfort The low-strength formulation is often used in pediatric patients as recommended by healthcare professionals Nasal spray delivery ensures targeted action directly at the site of congestion Widely prescribed by ENT specialists, pediatricians, and general physicians This strengthens a comprehensive ENT and respiratory care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxymetazoline 0.01% w/v Nasal Spray with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from seasonal and year-round demand in ENT and respiratory care, repeat purchases, reliable supply chain support, and attractive margins in the nasal care segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.